Skip to main content
Peter Mahler, MD, Radiation Oncology, Madison, WI

Peter A Mahler MD


Professor, Human Oncology, University of Wisconsin Medical School

Join to View Full Profile
  • 3220 Tallyho LNMadison, WI 53705

  • Phone+1 608-233-6732

Are you Dr. Mahler?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Peter Mahler, MD is a radiation oncologist in Madison, Wisconsin. He is currently licensed to practice medicine in Wisconsin and Illinois. He is a Professor at University of Wisconsin Medical School.

Education & Training

  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsResidency, Radiation Oncology, 1987 - 1991
  • University of Washington School of Medicine
    University of Washington School of MedicineClass of 1987
  • University of Wisconsin Hospitals and Clinics
    University of Wisconsin Hospitals and ClinicsFellowship, Hospice and Palliative Medicine

Certifications & Licensure

  • WI State Medical License
    WI State Medical License 1988 - 2023
  • IL State Medical License
    IL State Medical License 1994 - 2020
  • Radiation Oncology
    American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Press Mentions

  • New Coronavirus Strain Discovered in Ohio, Current Vaccines Believed Effective Against It
    New Coronavirus Strain Discovered in Ohio, Current Vaccines Believed Effective Against ItJanuary 13th, 2021
  • Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: The Single Most Important Factor in Determining the Future of SBRT Is Immune Response
    Three Discipline Collaborative Radiation Therapy (3DCRT) Special Debate: The Single Most Important Factor in Determining the Future of SBRT Is Immune ResponseOctober 3rd, 2019